Analysis of cell-free nucleic acids in the blood as biomarkers for diagnosis and therapy-evaluation of pancreatic, biliary and liver cancers.

Analysis of cell-free nucleic acids in the blood as biomarkers for diagnosis and therapy-evaluation of pancreatic, biliary and liver cancers. - Analysis of cell-free nucleic acids in the blood as biomarkers for diagnosis and therapy-evaluation of pancreatic, biliary and liver cancers.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014691

Enrollment

600

Registered

2014-07-30

Start date

2012-12-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients diagnosed or suspected as liver cancer, pancreatic cancer and biliary cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who diagnosed or suspected as liver cancer, pancreatic cancer and biliary cancer

Exclusion criteria

Exclusion criteria: Patients without informed consent.

Design outcomes

Primary

Measure	Time frame
To evaluate the clinical utility of cell-free nucleic acids in the blood.	—

Countries

Japan

Contacts

Public ContactMinoru Kitago

Keio University School of Medicine Department of Surgery

contact@keio-hpbts.jp03-5363-3802

Outcome results